Oil Prices Were Mixed in the Morning Asian Session • Gold Prices Slipped Below $5,000 in Thin Trading • Trump Says He Will Be Involved Indirectly in U.S.-Iran Nuclear Talks in Geneva • Global Investors Stay 'Uber-Bullish' as AI Bubble Fears Rise • Aluminum Surges on Trump Tariff Rollback Talk • Oil Prices Were Mixed in the Morning Asian Session • Gold Prices Slipped Below $5,000 in Thin Trading • Trump Says He Will Be Involved Indirectly in U.S.-Iran Nuclear Talks in Geneva • Global Investors Stay 'Uber-Bullish' as AI Bubble Fears Rise • Aluminum Surges on Trump Tariff Rollback Talk
Merck is acquiring Terns Pharmaceuticals, Inc., a biotech firm focused on developing novel treatments for hematological disorders, in a move to expand its hematology pipeline.…
35d agoBristol-Myers Squibb Company ($BMY) hits a 52-week high as sales of its cancer treatment drug Breyanzi surge, with…
68d ago⚡ TL;DR Nektar Therapeutics ($NKTR) has priced a $400 million public offering of common stock and pre-funded warrants,…
76d agoGet the 10 most important stories delivered to your inbox every morning. No spam. Unsubscribe anytime.